[go: up one dir, main page]

NO20020571D0 - Peptider som blokkerer virusinfeksjonsevnen og fremgangsmåter for anvendelse av disse - Google Patents

Peptider som blokkerer virusinfeksjonsevnen og fremgangsmåter for anvendelse av disse

Info

Publication number
NO20020571D0
NO20020571D0 NO20020571A NO20020571A NO20020571D0 NO 20020571 D0 NO20020571 D0 NO 20020571D0 NO 20020571 A NO20020571 A NO 20020571A NO 20020571 A NO20020571 A NO 20020571A NO 20020571 D0 NO20020571 D0 NO 20020571D0
Authority
NO
Norway
Prior art keywords
peptides
methods
block
viral infectivity
infectivity
Prior art date
Application number
NO20020571A
Other languages
English (en)
Other versions
NO20020571L (no
Inventor
Anders Vahlne
Original Assignee
Tripep Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tripep Ab filed Critical Tripep Ab
Publication of NO20020571D0 publication Critical patent/NO20020571D0/no
Publication of NO20020571L publication Critical patent/NO20020571L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition
    • Y10S977/916—Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20020571A 1999-08-09 2002-02-05 Peptider som blokkerer infeksjonsevnen, og fremgangsmåter for anvendelse av disse NO20020571L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/370,368 US6258932B1 (en) 1999-08-09 1999-08-09 Peptides that block viral infectivity and methods of use thereof
PCT/IB2000/000961 WO2001010456A2 (en) 1999-08-09 2000-06-29 Peptides that block viral infectivity and methods of use thereof

Publications (2)

Publication Number Publication Date
NO20020571D0 true NO20020571D0 (no) 2002-02-05
NO20020571L NO20020571L (no) 2002-04-05

Family

ID=23459335

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020571A NO20020571L (no) 1999-08-09 2002-02-05 Peptider som blokkerer infeksjonsevnen, og fremgangsmåter for anvendelse av disse

Country Status (15)

Country Link
US (2) US6258932B1 (no)
EP (1) EP1206273A2 (no)
JP (1) JP2003506410A (no)
KR (1) KR20020025970A (no)
CN (1) CN1377275A (no)
AU (1) AU5700800A (no)
CA (1) CA2378460A1 (no)
CZ (1) CZ2002402A3 (no)
HU (1) HUP0202502A2 (no)
IL (1) IL147969A0 (no)
IS (1) IS6262A (no)
MX (1) MXPA02001344A (no)
NO (1) NO20020571L (no)
PL (1) PL354090A1 (no)
WO (1) WO2001010456A2 (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL147970A0 (en) * 1999-08-09 2002-09-12 Tripep Ab Pharmaceutical compositions containing tripeptides
FR2827170B1 (fr) * 2001-07-13 2004-07-16 Soc Extraction Principes Actif Utilisation de peptides pour augmenter l'adhesion cellulaire
US6593455B2 (en) * 2001-08-24 2003-07-15 Tripep Ab Tripeptide amides that block viral infectivity and methods of use thereof
US6455670B1 (en) * 2001-09-06 2002-09-24 Tripep Ab Pentamer peptide amide, ALGPG-NH2, that inhibits viral infectivity and methods of use thereof
EP1436317A1 (en) * 2001-09-19 2004-07-14 Tripep Ab Molecules that block viral infectivity and methods of use thereof
SI2219031T1 (sl) * 2001-10-22 2013-11-29 Amgen, Inc. Uporaba leptina za zdravljenje lipoatrofije pri ljudeh in metoda za ugotavljanje dovzetnosti za navedeno zdravljenje
AU2003231012B2 (en) * 2002-04-22 2008-05-08 University Of Maryland, Baltimore County Antiviral inhibitions of capsid proteins
AU2003241103A1 (en) * 2002-04-23 2003-11-10 Umberto Dianzani Compositions containing anti-hiv peptides and methods of use
US20040180893A1 (en) * 2003-02-21 2004-09-16 Balzarini Jan Maria Rene Identification of compounds that inhibit replication of human immunodeficiency virus
US20050096319A1 (en) * 2003-02-21 2005-05-05 Balzarini Jan M.R. Identification of compounds that inhibit replication of human immunodeficiency virus
DE102005015005A1 (de) * 2005-04-01 2006-10-05 Qiagen Gmbh Verfahren zur Behandlung einer Biomoleküle enthaltenden Probe
TWI457136B (zh) 2005-04-04 2014-10-21 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
EP2160196A2 (en) * 2006-01-13 2010-03-10 Oncoreg AB Compounds for the treatment of ischemia and neurodegeneration
AU2007207544A1 (en) 2006-01-17 2007-07-26 Health Research, Inc. Heteroduplex tracking assay
JP5754005B2 (ja) 2006-01-20 2015-07-22 ヤンセン・アールアンドデイ・アイルランド Ｔｃｍ２７８を用いるｈｉｖ−感染症の長期間処置
WO2008004610A1 (en) * 2006-07-05 2008-01-10 The University Of Tokyo Method of treating genetic disease caused by nonsense mutation
WO2009000296A2 (en) * 2007-06-25 2008-12-31 Oncoreg Ab Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection
AU2009279616A1 (en) 2008-08-08 2010-02-11 New York Blood Center Small molecule inhibitors of retroviral assembly and maturation
CN101845079B (zh) * 2009-03-27 2014-04-09 中国人民解放军军事医学科学院毒物药物研究所 六肽或其衍生物及其医药用途
JP5664992B2 (ja) * 2009-08-26 2015-02-04 国立大学法人名古屋大学 細胞特異的ペプチド及びその用途
JP6174489B2 (ja) 2010-09-28 2017-08-02 アエゲリオン ファーマシューティカルズ，インコーポレイテッド 高可溶性レプチン
US9550811B2 (en) 2010-12-02 2017-01-24 Bionor Immuno As Peptide scaffold design
EP2913338A1 (en) * 2014-02-28 2015-09-02 Roche Diagniostics GmbH Soluable and immunoreactive variants of HTLV capsid antigen p24
US12029783B2 (en) * 2019-07-02 2024-07-09 Virago Vax Inc. Mammary tumor virus vaccine
US12016844B2 (en) 2019-07-02 2024-06-25 Virago Vax Inc. Mammary tumor virus suppression
CN111116717B (zh) * 2020-01-03 2021-10-29 中国科学院大学温州研究院(温州生物材料与工程研究所) 含有n-甲基-d-葡糖胺单元的糖肽水凝胶、制备方法及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215112A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Tripeptides and methods
US4658013A (en) * 1981-07-28 1987-04-14 Sterling Drug Inc. Analgesic and/or opiate antagonist tripeptide amides and processes for preparation and compositions thereof
US4818540A (en) 1985-02-25 1989-04-04 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
US4612337A (en) 1985-05-30 1986-09-16 The Trustees Of Columbia University In The City Of New York Method for preparing infection-resistant materials
US4952411A (en) 1987-02-25 1990-08-28 Trustees Of Columbia University In The City Of New York Method of inhibiting the transmission of AIDS virus
US4950647A (en) * 1988-10-04 1990-08-21 Nucleic Acid Research Institute T cell immunopotentiator
IT1231342B (it) 1989-08-28 1991-11-28 Prodotti Antibiotici Spa Derivati peptidici farmacologicamente attivi e preparazioni farmaceutiche che li contengono
DE4014655A1 (de) * 1990-05-08 1991-11-14 Behringwerke Ag Peptidamide, verfahren zu deren herstellung und diese enthaltende mittel als fibrin/thrombin-gerinnungsinhibitoren
US5346989A (en) * 1990-08-22 1994-09-13 Syntello Vaccine Development Kb Peptides for use in induction of T cell activation against HIV-1
US5627035A (en) 1990-08-22 1997-05-06 Syntello Vaccine Development Ab Peptides that block human immunodeficiency virus and methods of use thereof
GB9024129D0 (en) * 1990-11-06 1990-12-19 Thrombosis Research Trust Inhibitors and substrates of thrombin
WO1992020795A1 (en) 1991-05-17 1992-11-26 Cetus Oncology Corporation INHIBITOR OF NF-λB TRANSCRIPTIONAL ACTIVATOR AND USES THEREOF
NZ280932A (en) * 1995-02-07 1996-12-20 Mitsui Toatsu Chemicals Soil fumigant preparations; stick-shaped device comprising a water-soluble and/or biodegradable film incorporating a soil steriliser and/or a nematocide; ribbon and net shaped preparations; herbicide containing chloropicrin
US5817626A (en) * 1995-03-14 1998-10-06 Praecis Pharmaceuticals Incorporated Modulators of beta-amyloid peptide aggregation
US5770620A (en) * 1995-06-19 1998-06-23 Ontogen Corporation Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
US5872210A (en) * 1995-10-05 1999-02-16 The United States Of America As Represented By The Department Of Health And Human Services Transframe peptide inhibitor of viral protease
JP2000507828A (ja) * 1996-03-29 2000-06-27 ザ トラスティーズ オブ ボストン ユニバーシティー アルツハイマー病の診断および治療法
US6126939A (en) 1996-09-03 2000-10-03 Yeda Research And Development Co. Ltd. Anti-inflammatory dipeptide and pharmaceutical composition thereof
WO1998035062A1 (en) * 1997-02-07 1998-08-13 Lingappa Jaisri R Multistep, atp-dependent cell-free system for the assembly of human immunodeficiency virus capsids
US5843995A (en) 1997-07-07 1998-12-01 University Of Medicine And Dentistry Of New Jersey Inhibition of HIV-1 replication using oligocarbamate derivatives
WO1999009056A1 (en) 1997-08-19 1999-02-25 University Of Medicine And Dentistry Of New Jersey Inhibition of hiv-1 replication using d-amino acid peptides
AU5556799A (en) * 1998-08-12 2000-03-06 University Of Virginia Patent Foundation Assay for assembly of herpes simplex virus capsid
US6455670B1 (en) * 2001-09-06 2002-09-24 Tripep Ab Pentamer peptide amide, ALGPG-NH2, that inhibits viral infectivity and methods of use thereof

Also Published As

Publication number Publication date
CA2378460A1 (en) 2001-02-15
US20020091086A1 (en) 2002-07-11
WO2001010456A2 (en) 2001-02-15
CZ2002402A3 (cs) 2002-09-11
HUP0202502A2 (hu) 2002-11-28
IS6262A (is) 2002-02-08
PL354090A1 (en) 2003-12-29
CN1377275A (zh) 2002-10-30
AU5700800A (en) 2001-03-05
JP2003506410A (ja) 2003-02-18
IL147969A0 (en) 2002-09-12
MXPA02001344A (es) 2002-07-22
WO2001010456A3 (en) 2001-09-20
KR20020025970A (ko) 2002-04-04
EP1206273A2 (en) 2002-05-22
NO20020571L (no) 2002-04-05
US6258932B1 (en) 2001-07-10

Similar Documents

Publication Publication Date Title
NO20020571D0 (no) Peptider som blokkerer virusinfeksjonsevnen og fremgangsmåter for anvendelse av disse
NO20020635L (no) Hemmere av proteinpolymeriserings og metodene som brukes
NO20004104L (no) Preparater omfattende virus og fremgangsmater for konsentrering av viruspreparater
DK0965578T3 (da) Hidtil ukendt triglycerik og præparat, som omfatter dette
IS5943A (is) Aðferð og samsetningar til að endurheimta samræmdan stöðugleika próteina af p53 ættinni
NO20004582D0 (no) Sammensetninger og fremgangsmÕter for sementering ved anvendelse av elastiske partikler
DK1066049T3 (da) Farmaceutiske præparater, der er beregnet til langvarig frigivelse af peptider og fremgangsmåde til fremstilling af disse
DE69942895D1 (de) Replikons exprimierte ebola virion-proteine
DK0958292T3 (da) 4-3(3-heterocyclyl-1-benzoyl)pyrazoler og deres anvendelse som herbicider
EP1578771A4 (en) REMODELING AND GLYCOKON JUGATION OF PEPTIDES
NO992492D0 (no) Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
DK0944590T3 (da) Aminoguanidiner og alkoxyguanidiner som proteaseinhibitorer
DK1334182T4 (da) Fremgangsmåde til fremstilling af ikke-bovint chymosin og anvendelse heraf
NO20011162L (no) Fremgangsmåter og preparater for modulering av interaksjonen mellom APJ-reseptoren og HIV-viruset
NO20000853L (no) Polysiloksanbaserte blokk-kopolymerer og fremgangsmÕte for fremstilling av disse
EP1585391A4 (en) MITONEET POLYPEPTIDES FROM MITOCHONDRIUM MEMBRANES, MODULATORS THEREOF, AND METHOD OF USE THEREOF
DK0991666T3 (da) Alfa-1-antitrypsin-præparat og fremgangsmåde til fremstilling heraf
NO20005173D0 (no) Gen som koder for heliomicin og anvendelse derav
NO995513L (no) N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-
ATE348169T1 (de) Selektiv-replizierende virale vectoren
NO993437L (no) Koplingsanordning og fremgangsmåte til bruk av koplingsanordningen
NO20004349D0 (no) Metoder og anordninger for modulering av immunresponsen
NO20010464L (no) FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom
DK1021200T3 (da) Fremgangsmåder og præparater til behandling af rheumatoid arthritis
DK0949329T3 (da) Glutenfrit øl

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application